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Copyright # 200ABSTRACT: Aberrations in tumor and peritumoral vasculature may not be distinguishable by cerebral blood flow (CBF) or
cerebral blood volume (CBV) alone. The relationships between CBF and CBV were examined to estimate vasculature-
specific hemodynamic characteristics. Twenty glioma patients were studied with dynamic susceptibility T2
-weighted MRI
[(dynamic contrast-enhanced magnetic resonance imaging (DSC-MRI)] before and during week 1 and 3 of radiotherapy
(RT). CBF and CBV were calculated from DSC-MRI, and relationships between the two were evaluated: the physiological
measure of mean transit time (MTT)¼CBV/CBF; empirical fitting using the power law CBV¼ constant (CBF)b. Three
different tissue types were assessed: the Gd-enhancing tumor volume (GEV); non-enhanced abnormal tissue located beyond
GEV but within the abnormal hyperintense region on FLAIR images (NEV); normal tissue in the hemisphere contralateral to
the tumor (CNT). The effects of tissue types, CBVmagnitudes (low, medium and high), before and during RT, onMTTand b
were analyzed by analysis of variance (ANOVA). The MTT and b for the three tissue types were significantly different
(p< 0.009). MTT increased from CNT (1.60 s) to NEV (1.93 s) to GEV (2.28 s) (p< 0.0005). b was significantly greater in
GEV (1.079) and NEV (1.070) than in CNT (1.025). b increased with increasing CBV magnitude while MTT was
independent of CBV magnitude. There was a significant decrease in MTTof NEVand GEV during week 3 of RT compared
with pre-RT values for all CBV magnitudes. There was a significant increase in b during RT in the tumor and peritumor.
Progressive abnormalities in vasculature and hemodynamic characteristics of the vascular bed were delineated, with
significant disorder in the tumor but mild abnormality in peritumoral tissue. Copyright # 2007 John Wiley & Sons, Ltd.KEYWORDS: cerebral blood flow; cerebral blood volume; gliomas; mean transit time; radiotherapy; tumor vasculatureINTRODUCTION
One of the hallmarks of high-grade tumors is their
infiltrative nature. Owing to rapid growth of the tumor, the
core of the tumor becomes necrotic, while peripheral
tumor cells invade into the adjacent tissue, forming a
region in which tumor cells, edema and normal tissue
coexist. It is therefore difficult to estimate the tumor
margin for therapeutic targeting. However, given the
association between tumor growth and tumor neovascu-
larization, characterizing the functional and architectural
properties of vasculature in the tumor and peritumoral
region may aid in better delineation of the tumor
margin.
High-grade glioma vasculature exhibits a great degree
of heterogeneity in cerebral hemodynamic function andto: Y. Cao, Department of Radiation Oncology,
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21 CA11369901.
7 John Wiley & Sons, Ltd.morphological abnormalities. Increased vascularity is one
of the pathophysiological characteristics of high-grade
gliomas. Increased vascularity is more pronounced in the
contrast-enhanced rim on the post-Gd T1-weighted
image, whereas vessels in the tumor core undergo
regression, resulting in a low blood volume. The
peritumoral region, i.e. exterior to the enhanced rim,
presumably represents the area of tumor growth and
invasion into adjacent tissue. Vascular properties as well
as angiogenic activity and expression of growth factors in
the tumor and peritumoral region are likely to differ
from each other (1–3). Thus, vascular characterization
may provide valuable information on the tumor
margin. In addition, tumor vasculature may play a crucial
role in therapy (4). The effectiveness of radiotherapy,
chemotherapy or immunotherapy is dependent on the
function of the vasculature. Thus, an understanding of the
structural and functional/dysfunctional characteristics of
the vascular microenvironment in gliomas is essential for
design of therapeutic strategies.
Physiological imaging, especially dynamic contrast-
enhanced (DSC) magnetic resonance (MR) imaging hasNMR Biomed. 2007; 20: 566–577
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histopathological grading (5,7–11) and management of
cerebral tumors (12,13). Cerebral blood volume (CBV)
images estimated from DSC T2
-weighted imaging
have been used previously to differentiate between
microvascular changes after radiotherapy and tumor
recurrence (14) and to predict survival (10,15). In
high-grade gliomas, CBV and cerebral blood flow
(CBF) are elevated in the contrast-enhanced rim and
reduced in the tumor core and in the peritumoral region.
Thus, whether there is alteration in the vascular properties
of the peritumoral region that may be subtle and cannot be
easily distinguished by CBF and CBV abnormalities
alone remains to be evaluated. The objective of the
present study was therefore to examine the empirical and
physiological relationships between CBV and CBF to
estimate vasculature-specific hemodynamic functional
characteristics in order to distinguish tumor, peritumoral
and normal brain tissue. Specifically, this study evaluated
the mean transit time (MTT) determined as the ratio of
CBV to CBF, and the power exponent b, obtained from
the expression, CBV¼Constant x(CBF)b. The concept of
the power exponent was first proposed and studied by
Grubb in a hypercapnic rat model (16). The study was
also designed to evaluate these metrics pre radiation and
to assess time- and dose-dependent changes during
fractionated radiotherapy. It was hypothesized that the
empirical and physiological relationships between CBV
and CBF in the tumor and peritumoral tissue would
deviate significantly from that of normal tissue, with
severe dysfunction in the tumor and milder dysfunction in
the peritumor vasculature; moreover, tumor vasculatureTable 1. Summary of patient characteristics including tum
Patient number Gender Age (years) Histology Tum
1 F 44 GBM
2 M 39 GBM
3 F 31 GBM
4 M 66 GBM
5 F 54 GBM
6 M 60 GBM
7 F 44 AA
8 M 61 GBM
9 F 68 GBM
10 M 50 GBM
11 M 70 GBM
12 F 63 AO
13 F 58 GBM
14 F 23 GS
15 F 62 GBM
16 F 48 AO
17 M 76 AO
18 F 41 AO
19 F 62 GBM
20 F 73 GBM
Gender: F¼ female, M¼male; tumor histology: AA¼ anaplastic astrocyto
forme, GS¼ gliosarcoma; tumor grade: surgery (Sx¼ surgical resection,
three-dimensional conformal radiation therapy treatment.
Copyright # 2007 John Wiley & Sons, Ltd.will respond earlier to radiation therapy than the normal
tissue vasculature.METHODS
Patients
Twenty patients (13 females and seven males between the
ages of 23 and 76) with grade III (n¼ 5) or grade IV
(n¼ 15) gliomas participated in an institutional review
board approved clinical MRI study. Ten patients had
subtotal tumor resection and ten had biopsy only. All
patients had a minimum 4 cc residual tumor volume,
measured by volume of the contrast-enhanced region on
the post-contrast T1-weighted images. All patients
underwent three-dimensional conformal radiotherapy
(RT) with a median dose of 70Gy. MRI studies were
performed prior to RTand after 1–2 weeks (after a median
dose of 12Gy) and 3–4 weeks (after a median dose of
32Gy) during RT. A summary of patient characteristics
including tumor histology and treatment doses is detailed
in Table 1.MRI
The MRI protocol for all patients included axial
T1-weighted pre- and post-contrast, T2-weighted, fluid-
attenuated inversion recovery (FLAIR) and dynamic
contrast-enhanced (DSC) T2
-weighted images. For DSC
imaging, 36 volumes of dynamic T2
-weighted imagesor histology and radiation dose























ma, AO¼ anaplastic oligioastrocytoma, GBM¼ glioblastoma multi-
Bx¼ biopsy) and total accumulated dose received at the end of
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pulse sequence with TR¼ 2 s, TE¼ 60ms, field of
view¼ 220 220mm2, matrix¼ 128 128, flip angle¼
608 and 14 interleaved slices with 6mm thickness and a
0mm gap. The contrast agent Gd-DTPA (0.1mL/kg) was
injected intravenously by a power injector at a rate of
2mL/sec, followed immediately by 15mL of saline flush
at the same rate. The relative CBV and CBF in the brain
and tumor were computed from DSC T2
-weighted
images as described below.Image processing and perfusion calculation
All MR images acquired prior to and during RT were
coregistered to the post-contrast T1-weighted image set
acquired before RT. Image registration was performed
using mutual information and simplex optimization
algorithms. T2
-weighted images acquired with gradient-
echo echo-planar imaging were registered using affine
transformation which included 12 parameters (nine for
3 3 rotation and shearing matrix and three for
translation) to optimize and compensate for head motion,
slice misalignment and geometric distortion due to
magnetic field susceptibility. The CBV and CBF were
computed voxel by voxel using the methods outlined by
Rosen et al. (17), Østergaard et al. (18) and Liu et al. (19).
Details of these calculations are given in a previous paper
(15). In brief, the concentration of contrast agent in the
tissue, Ctiss(t), is the convolution of the arterial input
function (AIF) and the tissue residue function R(t), based
upon the theory of non-diffusable tracers. The equation
for Ctiss(t) was formulated as a matrix expression and
solved by a singular value decomposition (SVD) routine
(19,20). A small region in the middle cerebral artery was





The amplitude of the residue function is proportional to
the blood flow (CBF); and the integral of Ctiss(t) is
proportional to the blood volume (CBV). The SVD was
performed on a pixel-by-pixel basis to generate three-
dimensional CBV and CBF maps. To estimate CBV and
CBF, only the first pass peak of the bolus was used.Regions of different tissue types
The relationships between CBVand CBF were calculated
on a pixel-by-pixel basis and analyzed in three different
tissue types (see below). The three tissues were: (a) the
Gd-enhanced tumor volume which was defined on
post-contrast T1-weighted images and included the
contrast-enhanced rim and tumor core (or surgical cavity)
(GEV); (b) non-enhanced abnormal tissue that wasCopyright # 2007 John Wiley & Sons, Ltd.located beyond the GEV but within the T2 abnormal
hyperintense region on FLAIR images (NEV); (c) normal
tissue including all white matter and gray matter in the
hemisphere contralateral to the tumor and receiving much
less than 95% of the prescribed radiation dose to the
tumor (CNT). For patients in whom the tumor spanned the
right and left hemispheres of the brain, CNT was taken
from either the posterior or anterior region of the brain
that was remote from the site of the tumor. The CNT
volumes ranged from 78 to 310 cc with a mean CNT
volume of 203 cc, and the mean volume of tumor and
peritumor was 43 and 67 cc respectively.
For further analysis of the effects of radiation on the
relationships between CBV and CBF (see below) in all
normal appearing tissue, the normal appearing tissue was
divided into regions based upon received dose at the
completion of RT: (a) 4Gy; (b) >4 12Gy; (c) >12
 24Gy; (d) >24Gy 95% of the biologically corrected
dose (alpha/beta¼ 2.5) (21). The effect on the normal
appearing tissue that received >95% of the prescribed
tumor dose was also assessed. A pictorial configuration of
the various tissue types/regions studied is illustrated in
Fig. 1.Normalization
To assess the relationship between CBVand CBF over the
course of RT and across patients, CBV and CBF values
were normalized to white matter regions contralateral to
the tumor, an approach used in previous work by the
present authors (15). In brief, the white matter volumes of
interest for normalization were defined in the volumes
contralateral to the tumor and received <30Gy biologic-
ally corrected dose at the end of RT. The reason for
choosing <30Gy instead of a lower dose was to have a
sufficient volume of interest for every patient. Using CBF
and CBV values of white matter reported in the literature
(22,23), the mean CBV and CBF in the normal white
matter volume were normalized to 100mL/100 g and
30mL/100 g/min respectively. This normalization would
influence the absolute value of the mean transit time
(MTT¼ the ratio of CBV to CBF, further defined below)
but not affect changes in MTT from one tissue region to
another, or over the course of treatment. Also, this
normalization would not affect the power exponent
(defined below).CBV–CBF relations
The coupling between CBF and CBV was evaluated by
two different approaches:1. Mean transit time. The MTT was calculated on the
basis of the central volume principle (24), relating
CBF, CBV and MTT as follows: MTT¼CBV/CBF.NMR Biomed. 2007; 20: 566–577
DOI: 10.1002/nbm
Figure 1. Illustration of the volumes of interest of the different tissue types, and the spatial
relation and proximity of the volumes. FLAIR (left) and post-Gd-DTPA T1-weighted images
(right) were used to define the FLAIR tumor volume and Gd-DTPA contrast-enhanced tumor
volume (GEV). The volume of non-enhanced abnormal tissue (NEV) is the difference in the
FLAIR tumor volume and the GEV. The GEV is enclosed by the thick white contour, and the
NEV by the black contour on both panels. CNT that is contralateral to the tumor is denoted
by the white contour on the left panel. The volume of normal appearing tissue that received
95% of the biologically corrected radiation dose to the tumor (NA-95%) is adjacent to the
tumor and depicted by the outer white contour on the right panel
QUANTITATIVE CHARACTERIZATION OF GLIOMAVASCULATURE 5692. Power law. Empirical fitting of CBV and CBF using
the power law CBV¼A (CBF)b, where constants
A and b are the proportionality constant and power
exponent respectively. The power-law relationship
was estimated by fitting the rest-state CBV and CBF
data within a 5 5 voxel kernel to obtain maps of
A and b using least-squares minimization. The stat-
istical significance for fitting the 5 5 voxel was set at
p< 0.05. Therefore, voxels with p 0.05 were dis-
carded from the analysis. Deviation of the power
exponent b from unity indicates that the relationship
between CBV and CBF has departed from the central
volume principle.Definition and range of CBV magnitudes
To assess the dependence of MTT or power exponent on
CBV magnitudes, the MTT and the power exponent were
further evaluated on the basis of low, medium, and high
CBV magnitudes in each of the three tissue types (GEV,
NEVand CNT). The CBV classification scheme used was
identical to the one described in the previous study (15).
Briefly, the CBV values of normal white and gray matter
tissue reported in the literature were used to define the
threshold values of low, medium and high CBV. The low
CBVinterval was characterized as CBV being>0.2% andCopyright # 2007 John Wiley & Sons, Ltd.<1.75%, the medium CBV range was 1.75–4% and high
CBV was >4%. The cut-off threshold CBVof 0.2% was
used to exclude necrotic tissue or a surgical cavity in
which there was no CBV or very low CBV.Statistical analysis
Statistical analysis was performed with the commercially
available Statistical Software Package for Social Sciences
program (SPSS Software Products, Chicago, IL). Effects
of three factors – tissue type (GEV, NEVand CNT), CBV
magnitude (low, medium and high) and time of MRI scan
(pre-RT, week 1 during RT and week 3 during RT) – on
MTT were assessed. Three major effects on MTT and
interactions between these factors were analyzed by
factorial analysis of variance (ANOVA). Then, post hoc
analyses were performed to evaluate differences in MTT
between conditions. A p value of <0.05 was considered
significant. Similar analyses were applied to the power
exponent. Descriptive statistics (mean and standard
deviation) were also obtained.
In the normal appearing tissue regions, which were
divided into five subregions based upon received
biologically corrected doses, the effects of radiation dose
and time of scan on the power exponents were also
analyzed by factorial ANOVA.NMR Biomed. 2007; 20: 566–577
DOI: 10.1002/nbm
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Visualization of tumor perfusion
heterogeneity
Tumor heterogeneity in high-grade gliomas was mani-
fested by a complex pattern of low, medium and high
CBV distribution in all patients. Examples from two
patients with different distribution patterns are illustrated
in Fig. 2. In the first patient (Fig. 2, top row), one
low-CBV region was central and presumably was
predominantly necrotic tissue, while another was on
the outer rim. The high-CBV region corresponded
approximately to the enhancing rim. The medium-CBV
regions were concentrically situated between the
high-CBV region and the inner and outer low-CBV
regions. In contrast, in another patient (Fig. 2, bottom
row) the high-CBV region formed the outer border of the
tumor, with pockets of medium and low CBV in itsFigure 2. Examples of vascular and spatial hete
cerebral blood volume in tumor and peritumoral
from two representative cases, patient 13 (top
Table 1 are illustrated. Shown in the left colum
(blue), medium-CBV (yellow) and high-CBV (red)
are the post-Gd T1-weighted images. The FLAIR
peritumor tissue is represented by the white cont
An illustration of CBV heterogeneity in peritum
image, top row): low CBV is represented by t
high-CBV by the magenta regions. In the right co
the color bar on the right. Note the complex p
which one region of low CBV was located in the
the outer rim of the tumor, the high-CBV re
enhancing rim and the medium-CBV region wa
inner and outer low-CBV regions. In the sec
coincident with the outer border of the tumor
medium CBV
Copyright # 2007 John Wiley & Sons, Ltd.vicinity. Complex patterns of CBV heterogeneity were
also noted in tissue adjacent to the tumor, i.e. peritumoral
tissue. Perfusion heterogeneity in tumor and surrounding
tissue is highly suggestive of differences in vasculature
that likely contribute to distinct forms of pathology.
Some general observations can be made about spatial
distributions of the low and high CBV in different
pathological tissue. Low CBV in the tumor (GEV) was
generally coincident with the tumor core which was
hyperintense on the FLAIR/T2 images and possibly
signified necrosis. High CBV in the GEV was mapped
onto the contrast-enhanced rim on the post-Gd T1-weighted
image. In some patients, high CBV in NEV did not
correspond to specific features on T2 and T1 anatomical
images. Low CBV in the NEV region was coincident with
the hypointense region on T1-weighted images and the
hyperintense region of the T2-weighted images, and it was
contiguous with the contrast-enhanced rim on the
T1-weighted images.rogeneity in the distribution patterns of the
tissue was observed for all patients. Images
row) and patient 20 (bottom row) listed in
n are FLAIR images on which the low-CBV
contours are overlaid. In the center column
tumor volume comprising the tumor and
our in themiddle lower image (patient 20).
oral tissue is shown for patient 13 (center
he cyan, medium CBV by the green and
lumn are the color-coded CBV maps, with
atterns of tumor vasculature (top row) in
tumor center while another region was on
gion corresponded approximately to the
s located between the high-CBV and the
ond case (bottom row), high CBV was
surrounded by compartments of low and
NMR Biomed. 2007; 20: 566–577
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Table 2. Average of the mean transit times (MTTs) and SD for the low, medium and high CBV of the different tissue
types before and during the course of radiation therapy
Tissue
MTT (s)
Low CBV Medium CBV High CBV
Pre Week 1 Week 3 Pre Week 1 Week 3 Pre Week 1 Week 3
CNT 1.62 0.18 1.62 0.15 1.65 0.15 1.53 0.24 1.53 0.21 1.50 0.15 1.65 0.42 1.77 0.69 1.56 0.24
NEV 1.89 0.33 1.86 0.27 1.74 0.24 1.86 0.36 1.86 0.24 1.74 0.21 2.04 0.42 2.13 0.57 1.86 0.27
GEV 2.19 0.60 2.13 0.45 1.95 0.51 2.22 0.63 2.16 0.48 2.01 0.39 2.43 0.78 2.25 0.75 2.10 0.54
Key to abbreviations: CNT¼ normal tissue in hemisphere contralateral to the tumor site and receiving less than 95% of the prescribed radiation dose;
NEV¼ non-enhanced abnormal tissue that was located beyond the Gd-enhanced tumor volume but within the T2 abnormal hyperintense region on
FLAIR images; GEV¼Gd-enhanced tumor volume that was defined on post-contrast T1-weighted images.
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The MTTs calculated using the central volume principle
for different tissue types and CBVmagnitudes before and
during the course of RT are summarized in Table 2.
Factorial ANOVA indicated strong evidence of the main
effects of tissue type (p< 0.0005) and time of the MRI
scan (p¼ 0.002) but no effect of CBV magnitude
(p> 0.09) on MTT. There was no evidence of two-way
or three-way interactions between tissue type, time of
scan and CBV magnitude (p> 0.2) (see Table 3).
Post hoc analysis revealed that MTT values were
elevated significantly (p< 0.0005) in GEV and NEV
compared with CNT, longest in GEVand shortest in CNT.
Also, MTT did not change significantly after 1 week of
RT but changed significantly after 3 weeks of RT. MTTatTable 3. Summary of factorial ANOVA of the effects of tiss
(low versus medium versus high) and time of MRI scan (pre v
and power exponent b, as well as interaction effects and po




CBV magnitude p¼ 0.09
Tissue type p< 0.00
Interaction effects – two-way
Time–CBV magnitude p¼ 0.21
Time–tissue type p¼ 0.47
CBV magnitude–tissue type p¼ 0.83
Interaction effects – three-way
Time–CBV magnitude–tissue type p¼ 0.99
Post hoc analysis
Time Pre-RT versus week 1
Pre-RT versus week
Week 1 versus wee
CBV magnitude Low versus medium
Low versus high n
Medium versus high
Tissue type CNT versus NEV
CNT versus GEV
NEV versus GEV
Copyright # 2007 John Wiley & Sons, Ltd.week 3 during RT was significantly decreased compared
with MTT at week 1 of RT or pre-RT (p 0.02) (Table 3
and Fig. 3). In the GEVand the NEV, MTT of high CBV
was significantly elevated compared with one with low or
medium CBV (p< 0.05), but there was no significant
difference between the MTT values of low and medium
CBV (p> 0.2) when the data were combined over all time
points.Power law
Values for the power exponent b, obtained before and
during RT in the different tissue types and with the
different CBV magnitudes, are summarized in Table 4.
Results of the factorial ANOVA of main effects andue type (CNT versus NEV versus GEV), CBV magnitude
ersus week 1 versus week 3 during RT) on the time MTT
st hoc analysis of these factors, tabulated with the level








not significant Pre-RT versus week 1 p¼ 0.04
3 p¼ 0.002 Pre-RT versus week 3 p¼ 0.01
k 3 p¼ 0.02 Week 1 versus week 3 not significant
not significant Low versus medium p< 0.0005
ot significant Low versus high p< 0.0005
not significant Medium versus high p< 0.0005
p< 0.0005 CNT versus NEV p¼ 0.002
p< 0.0005 CNT versus GEV p< 0.0005
p< 0.0005 NEV versus GEV not significant
NMR Biomed. 2007; 20: 566–577
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Figure 3. Factorial ANOVAwas used to study the main effects of time of MRI scan in the left column (pre and weeks 1 and 3
during radiotherapy), CBV magnitude (low, medium and high) in the center column and tissue type (GEV, NEV and CNT) in
the right column on the MTT (top-row graphs) and the power exponent b (bottom-row graphs) illustrated by the bar graphs.
Significance was assumed at p< 0.05. There was strong evidence of the main effects of tissue type (p<0.0005) and time of
MRI scan (p<0.002), but there was no effect of CBV magnitude on MTT (p>0.09). There was very strong evidence of the
main effects of CBV magnitude (p< 0.0005), tissue type (p<0.0005) and time of scan (p¼ 0.007) on b (bottom panel of
graphs)
572 V. NAGESH ET AL.interactions between the three factors of tissue types, time
of scan and CBV magnitudes on the power exponents are
outlined in Table 3. There was very strong evidence of the
main effects of CBVmagitudes (p< 0.0005), tissue types
(p< 0.0005) and time of scan (p¼ 0.007) on the power
exponent. There was a significant two-way interaction
between CBV magnitudes and tissue types (p< 0.0005)
(see Fig. 4), but interactions among the other factors were
not significant.Table 4. MeanSD of the power exponent b before and at w
different tissue types in the low, medium and high CBV, obta




Pre Week 1 Week 3 Pre W
CNT 0.90 0.06 0.91 0.06 0.93 0.06 1.02 0.08 1.03
NEV 0.97 0.10 1.00 0.12 1.02 0.09 1.05 0.12 1.07
GEV 1.03 0.13 1.07 0.13 1.05 0.10 1.06 0.15 1.09
Key to abbreviations: CNT¼ normal tissue in hemisphere contralateral to the
NEV¼ non-enhanced abnormal tissue that was located beyond the Gd-enhan
FLAIR images; GEV¼Gd-enhanced tumor volume that was defined on po
Copyright # 2007 John Wiley & Sons, Ltd.The post hoc analysis revealed that the power
exponents increased with increasing CBV (p< 0.0005)
(Fig. 3). The power exponents in the NEVand GEV were
significantly greater than that in the CNT; but the
exponent in the NEV was not significantly different from
that in the GEV (Fig. 3). In the GEV, the power exponent
of high CBVwas lower whereas the exponents of low and
medium CBV were higher compared with the corre-
sponding values in NEV and CNT, as indicated by theeeks 1 and 3 during the course of radiotherapy for the
ined by empirically fitting CBV and CBF. The non-linear
the following fit: CBV¼ constant (CBF)b
coefficient
um-CBV High-CBV
eek 1 Week 3 Pre Week 1 Week 3
 0.08 1.04 0.05 1.11 0.19 1.13 0.11 1.15 0.08
 0.11 1.08 0.09 1.10 0.18 1.18 0.14 1.15 0.09
 0.14 1.11 0.14 1.06 0.18 1.13 0.15 1.12 0.12
tumor site and receiving less than 95% of the prescribed radiation dose;
ced tumor volume but within the T2 abnormal hyperintense region on
st-contrast T1-weighted images.
NMR Biomed. 2007; 20: 566–577
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Figure 4. Factorial ANOVA of the two-way interaction
between the three independent factors of CBV magnitude
(low, medium and high), tissue type (GEV, NEV and CNT) and
time of MRI scan (pre versus during radiation therapy)
indicated that there was a significant interaction effect only
between CBV magnitude (low, medium and high) and tissue
type (GEV, NEV and CNT) for the power exponent dependent
variable (p<0.0005); all other two-way and three-way
interactions for MTT and b were not significant (Table 3).
Note that, for high CBV, the power exponent in the tumor
(GEV, cross symbol) was smaller than in the peritumor (NEV,
open circle symbol) and normal tissue (CNT, solid diamond
symbol). The power exponent of high CBV in the tumor
(GEV) was smaller than that of peritumor (NEV) or normal
(CNT) tissue, whereas the exponents of low and medium
CBV in GEV were larger than the corresponding values in
NEV and CNT
QUANTITATIVE CHARACTERIZATION OF GLIOMAVASCULATURE 573interaction of the effects between tissue type and CBV
magnitude (Fig. 4). Post hoc analysis of the time of scans
indicated an increase in the power exponent after RT
compared with the pre-RT values (p< 0.05) (see
Table 3).Effect of dose on power exponent
in normal tissue
The effects of radiation dose on the power exponent
characteristics in normal tissue surrounding the tumor
were further examined. The power exponents in normal
appearing tissue were assessed in five regions that
received biologically corrected doses of (a) 4Gy,
(b) 4–12Gy, (c) 12–24Gy, (d) 24Gy to 95% of the
prescribed dose and (e) >95% of the prescribed dose.
Factorial ANOVA of the power exponent indicated no
effect of dose (p¼ 0.42) or time of MRI scan (p¼ 0.23)
in the normal appearing tissue.DISCUSSION
Quantitative characterization of the physiological and
empirical correlation/coupling between cerebral blood
volume and cerebral blood flow provided inherentlyCopyright # 2007 John Wiley & Sons, Ltd.different information about tumor vasculature. The
present study found that the MTT was sensitive to tissue
type (normal versus abnormal) and time of MRI scan
(pre-therapy versus during radiation therapy) but was
independent of CBV magnitude. In contrast, the power
exponent was strongly dependent on CBV magnitude
(low versus medium versus high), tissue type [normal
(CNT) versus both non-enhancing abnormal (NEV) and
Gd-DTPA contrast-enhanced (GEV) pathologies] and
time of scan (pre-therapy versus during radiation therapy
or received radiation dose). Therewas mild but significant
abnormality in the microvascular function (as measured
by MTT) of peritumoral tissue (NEV) and severe
dysfunction in the tumor (GEV). Prolonged MTT in
tumor and peritumoral tissuewhen compared with normal
tissue suggests increased vessel tortuosity and/or
decreased blood velocity (see below). In normal tissue,
the power exponent increased with increasing CBV
magnitude, but in GEV the exponent was nearly constant
for all CBV magnitudes, likely owing to loss of
physiological distinction among arterioles, capillaries
and venules in the tumor. Elevation in the low- and
medium-CBV power exponent of GEV compared with
that of normal tissue indicates that the tumor vascular bed
provides a smaller amount of blood flow to the same
amount of blood volume, most likely owing to
disorganized, chaotic and irregular vessels in the tumor.
Taken together, the present study suggests that the MTT
and the power exponent metrics provide additional
information on hemodynamic properties and vasculature
dysfunction of glioma from CBVand CBF, not previously
reported.
Significant differences in the MTTand power exponent
of normal tissue and tumor suggest that both hemody-
namic function and structural changes in the glioma
vasculature affect CBV, CBF and the relationship
between CBV and CBF. The glioma vessel morphology
exhibits chaotic and irregular vascular branching patterns
with enlarged but variable vessel diameters and variable
vessel density (25–28). The glioma vessels lack the usual
distinctive anatomic features and do not conform to the
physiological microvasculature of brain tissue (27,29). It
is therefore a challenge to assess in vivo structural and
morphological changes in tumor vasculature. However,
these anatomical abnormalities would be expected to be
accompanied with hemodynamic abnormalities in CBF
and CBV. In the present study, the relationship between
CBV and CBF was evaluated to study vascular
abnormalities to measure the influence of structural
abnormalities on functions of vasculature in tumor and
peritumoral tissue.
A striking feature of the power exponent analysis was
the ability of this metric qualitatively to differentiate
between vessels on the basis of the hemodynamic
functional characteristics of vessels in normal and
abnormal tissue. The morphological abnormalities of
the glioma vasculature, such as enlargement of the vesselNMR Biomed. 2007; 20: 566–577
DOI: 10.1002/nbm
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tion among arterioles, capillaries and venules, can affect
perfusion characteristics. Study of the power-law
relationship between CBV and CBF provided insight
into these abnormalities. The present data show that in
normal tissue the power exponent is approximately 1 for
medium CBV which roughly corresponds to gray matter,
less than 1 for low CBV which mainly represents white
matter (Table 4) and greater than 1 for high CBV which
mainly represents macrovessels. Large vessels are
typically located at the surface of the brain, and gray
matter is primarily in the brain cortex, but, owing to the
proximity of gray matter to large vessels at the surface of
the brain, there could be some contamination from the
large vessels with a partial volume effect, resulting in a
power exponent higher than the expected value of 1 for
gray matter. These data indicate that the relationship
between CBF and CBV differs in normal brain,
depending on the presence of microvasculature, macro-
vasculature or a mix of the twowithin a voxel. In contrast,
the power exponents in GEV were greater than 1 for all
CBV magnitudes (Fig. 4), suggesting that the behavior of
the tumor vasculature differs from that of microvascular
structures, especially for low andmediumCBV. However,
combining the observations of the power exponent and
the MTT, the vasculature in the tumor is substantially
different from macrovasculature in normal brain, as
suggested by the elevated MTT in the tumor for all CBV
magnitudes compared with both micro- and macrovas-
culature in normal brain. In addition, in the NEV region,
the power exponents of low and medium CBV were
intermediate between those of CNT and GEV (Fig. 4),
suggesting that the microvasculature in the peritumoral
region undergoes abnormal changes, possibly modified
by infiltrated tumor cells. In sum, the power exponent is a
metric that provides qualitative assessment of structural
and anatomical changes in the vessel.
Irregular and disorganized glioma vessel architecture
can greatly affect the hemodynamic functional efficiency
of the tumor vasculature, which can be assessed by the
MTT (the ratio of CBV to CBF). It was found that
the MTTs in tumor (GEV) and peritumor (NEV) were
prolonged relative to the MTT in normal tissue (CNT),
signifying diffuse hemodynamic impairments from the
solid tumor to peritumoral tissue (Table 2 and Fig. 3). The
prolonged MTT in the tumor and the peritumoral tissue is
possibly due to the disordered and irregular branching of
the tumor vessels, resulting in increased tortuosity of the
vasculature. The increased MTT in abnormal tissue could
represent two conditions: (1) regions with low CBV and
very low CBF; (2) regions with high CBV and little
change in CBF. As pointed out earlier, there are two
regions in which CBV is low and MTT is elevated. One is
in the GEV and coincident with the tumor core (but
excluding necrosis and surgical cavity) (see the methods
section). In the tumor core, the vasculature has been
described as regressed with decreased vessel density (26).Copyright # 2007 John Wiley & Sons, Ltd.The other is in the NEV region in which there coexist
tumor cells, edema and normal tissue. There are no
previous reports that describe any vascular dysfunction
and morphological abnormality in the vasculature of the
peritumoral region (NEV) except for a decrease in CBV
which can be caused by an increase in intracranial
pressure owing to edema formation but without vascular
dysfunction and morphological changes in vasculature
(26). A decrease in both CBF and CBV in NEV could also
be related to expansion of tissue by edema or by
infiltrating tumor cells in the absence of new vessels. The
present findings of the prolonged MTT and the elevated
power exponent in the NEV region compared with
normal tissue indicate that the vasculature is both
functionally and structurally abnormal. This region is
likely a dynamic growth region that will expand into
surrounding tissue. In the tumor, the region that has both
an elevated MTT and CBV was coincident with the
contrast-enhanced rim on the post-Gd T1-weighted
images, indicating maximum vascularity and perfusion
deficiency. These facts may signify the growth of newly
formed vessels that lack the normal vessel structure,
suggesting angiogenesis. The rapid growth of new vessels
and loss of existing blood vessels will likely contribute to
fluctuations in blood flow patterns of the tumor. These
observations point to MTTas a functional metric of tissue
vasculature.
Radiation injury to vasculature generally is long latent
after completion of radiation therapy. A low irradiation
dose that is insufficient to produce white matter necrosis
may cause vascular abnormality owing to the high
radiosensitivities of vascular cells (30). Endothelial cells
are most sensitive to irradiation of all the cells that
constitute the vessel wall. Morphological analysis of
microvessels of irradiated rat cervical spinal cord
showed a reduction in endothelial cells only in white
matter 3 months after radiation (31). An increase in
vascular permeability has been observed in animal
models (32) and in patients (33) during and shortly after
radiation therapy, which may be a transient effect. The
increase in vascular permeability leads to edema and
fibrin deposition in the interstitial space, and blood vessel
walls and extravagated fibrin are subsequently replaced
by collagen fibers, followed by atrophy of parenchymal
tissue (30). However, how radiation produces disruption
of BBB is unresolved, and the precise mechanism remains
to be determined.
The MTT and power exponent in GEV and NEV were
both affected during the early phase of radiation,
signifying that vascular functional changes are accom-
panied with morphological changes. In GEV and NEV,
the MTT was reduced significantly at week 3 of RT but
not at week 1 of RT, suggesting improvement in function
of the vasculature at week 3 of RT; meanwhile, the power
exponents increased significantly at week 1 and changed
little at week 3 of RT. In contrast, therewere no changes in
either the power exponent or the MTT in contralateralNMR Biomed. 2007; 20: 566–577
DOI: 10.1002/nbm
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that there were no important effects of radiation on
the cerebral hemodynamic properties of normal vascu-
lature during the first 3 weeks of radiation. However, there
were significant changes in hemodynamic function of the
tumor and peritumor vasculature during the first 3 weeks
of RT.
Cerebral blood volume can be under- or overestimated
in regions of the tumor where there is breakdown of the
blood–brain/tumor barrier. In these regions, extravasation
of the contrast agent into the interstitium can result in T1
shortening, thereby causing underestimation of CBV. In
addition, extravascular contrast concentrations can be
miscounted as intravascular contrasts, resulting in an
overestimation. However, both the T1 effect and the
extravascular contribution can be minimized. Firstly, a
gradient-echo pulse sequencewith a longer TR of 2 s and a
smaller flip angle of 608were chosen in order to minimize
T1 effects. When visually inspecting DSC time courses in
the tumor, overshooting in the tails of the time courses
was never seen, suggesting that there were minimum T1
effects. Secondly, only the first pass was used to estimate
CBVand CBF, which minimized potential overestimation
and underestimation in respective CBV and CBF,
compared with using the entire DSC time courses.
The absolute values of the MTT and power exponent
can be influenced by several factors involving imaging
technologies and image processing. Firstly, the CBV
and CBF estimated by dynamic contrast-enhanced
T2
-weighted imaging are relative measures of these
parameters. In order to obtain MTT, both CBV and CBF
were normalized to normal white matter receiving less
than 30Gy. Scaling factors were chosen for CBVand CBF
on the basis of values reported in the literature for white
matter (22,23,34). The range of CBVand CBF values for
white matter reported in the literature is considerable,
depending upon the imaging technology used, the image
resolution and the subject/patient conditions (20,35–40).
As in their previous study, the present authors chose a
normal white matter CBV of 1% and a CBF of 30mL/
100 g/min (15). The mean MTT in normal tissue from the
cohort of 20 patients in this study was 1.60 0.28 s.
Nevertheless, assessment of the MTT changes over
different tissue types, in response to different radiation
doses, and dependency upon CBV magnitudes should not
be affected by the global scaling factor. Furthermore,
the power exponent is absolutely independent of the
scaling factor. Secondly, it is generally assumed that a
gradient-echo pulse sequence is not selective for vessel
size, thus hindering discrimination between microvascu-
lature and macrovasculature in normal tissue, and hence
CBV estimated by a gradient-echo pulse sequence is
more representative of total CBV (41,42). Given that the
physiological distinction between arterioles, capillaries
and venules is diminished in glioma vasculature, and that
the diameter of tumor vessels can increase up to 40mm
(43,44), it appears to be favorable to use the gradient-echoCopyright # 2007 John Wiley & Sons, Ltd.pulse sequence in high-grade gliomas, whereas a
spin-echo pulse sequence that is selectively sensitive to
vessels with a diameter less than that of capillaries (43)
may lose sensitivity to image the enlarged vessels in the
tumor (42). Thirdly, the power-law relationship between
CBV and CBF has been investigated previously
(15,16,24,45,46). In 1954, Meier and Zierler (24)
proposed the central volume principle as the linear
relation between CBV and CBF in which the power
exponent is unity. This linear relation has been
demonstrated to be valid in a large range of CBVs and
CBFs and in the rest state by experimental observations
(15,24,47,48). However, under different physiological or
pathological conditions, the relationship between CBV
and CBF might change. In 1974, Grubb et al. (16)
investigated the relationship between the relative changes
in CBV and CBF under hypercapnic challenges, and
found the power exponent to be 0.38. This non-linearity
between CBV and CBF is explained as the CO2-induced
increase in CBF owing to decrease in cerebral vascular
resistance occurring as a result of vasodilation (16).
Grubb’s relationship is also found to be true under
neuronal activation (49). The previous study by the
present authors (15) found that the rest-state regional
CBV and CBF were linearly correlated in high-grade
gliomas, and the linear correlation was approximately
maintained even after radiation. In the present study,
whether there was a deviation from the central volume
principle in high-grade gliomas and after radiation was
evaluated. Thus, b was evaluated for rest-state CBV and
CBF in spatially adjacent voxels. Finally, the authors
would like to point out that their methodology can
differentiate the power exponents of gray and white
matter (the power exponent was larger in medium-CBV
regions, which are predominantly gray matter, than in
low-CBV regions, which are predominantly white matter)
(see Table 4) and delineate the subtle differences in the
MTT between normal gray matter and white matter (MTT
was slightly longer in low-CBV regions, primarily white
matter, than in medium-CBV regions, predominantly
gray matter) (see Table 2).CONCLUSIONS
The cerebral hemodynamic functional and structural/
morphological characteristics of tumor vasculature in
high-grade gliomas can be assessed quantitatively and/or
qualitatively by the two metrics that are robustly obtained
from MRI-estimated cerebral blood volume and cerebral
blood flow. With these two metrics – the mean transit
time and the power exponent, progressive abnormalities
in vasculature function characteristics as a result of
alterations in structural properties of the tumor vascular
bed were detected, with more striking abnormalities in
tumor and milder abnormalities in peritumoral tissue. The
vasculature of normal appearing tissue surrounding theNMR Biomed. 2007; 20: 566–577
DOI: 10.1002/nbm
576 V. NAGESH ET AL.tumor was not affected by radiation dose delivered to the
tissue in the first 3 weeks during the course of radiation
therapy. Non-invasive surrogate markers of the vascu-
lature that provide information about the structural
properties as well as hemodynamic function are of value
in targeting and evaluating therapy.Acknowledgements
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